The current COVID-19 global pandemic continues to remain out of control. As we write this blog, over 60,000 new infections are being reported on a daily basis in the United States, with a cumulative total of over 4 million cases and over 150,000 deaths reported since the pandemic first began here.
Read MoreIndustry is rapidly developing novel coronavirus diagnostic tests for emergency use authorization by the FDA.
Read MoreObjective classification of adverse events has been a challenge for the industry. An outcome-based, medically-focused classification framework offers a more robust approach.
Read More